Macquarie Group LTD Neogenomics Inc Transaction History

Macquarie Group LTD

$80.3 Billion
Q1 2025

A detailed history of Macquarie Group LTD transactions in Neogenomics Inc stock. As of the latest transaction made, Macquarie Group LTD holds 4,676,622 shares of NEO stock, worth $34 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

4,676,622

Previous 3,812,229 22.67%

Holding current value

$34 Million

Previous $62.8 Million 29.36%

% of portfolio

0.06%

Previous 0.07%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$9.09 - $18.61 $7.86 Million - $16.1 Million	864,393 Added 22.67%	4,676,622 $44.4 Million
Q4 2024 Feb 14, 2025	SELL	$13.0 - $18.43 $161,057 - $228,329	-12,389 Reduced 0.32%	3,812,229 $62.8 Million
Q3 2024 Nov 14, 2024	BUY	$13.4 - $17.73 $7.52 Million - $9.95 Million	561,232 Added 17.2%	3,824,618 $56.4 Million
Q2 2024 Aug 09, 2024	SELL	$13.01 - $15.77 $9.89 Million - $12 Million	-760,123 Reduced 18.89%	3,263,386 $45.3 Million
Q1 2024 May 14, 2024	SELL	$14.06 - $16.79 $810,840 - $968,279	-57,670 Reduced 1.41%	4,023,509 $63.2 Million
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $12.4 Million - $22 Million	1,062,226 Added 35.19%	4,081,179 $66 Million
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $9.1 Million - $13.4 Million	748,900 Added 32.99%	3,018,953 $37.1 Million
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $3.46 Million - $4.87 Million	245,699 Added 12.14%	2,270,053 $36.5 Million
Q1 2023 May 15, 2023	BUY	$9.09 - $19.45 $507,040 - $1.08 Million	55,780 Added 2.83%	2,024,354 $35.2 Million
Q4 2022 Feb 21, 2023	BUY	$6.45 - $12.07 $324,422 - $607,096	50,298 Added 2.62%	1,968,574 $18.2 Million
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $261,439 - $429,412	33,262 Added 1.76%	1,918,276 $16.5 Million
Q2 2022 Aug 15, 2022	SELL	$7.06 - $13.97 $745,486 - $1.48 Million	-105,593 Reduced 5.3%	1,885,014 $15.4 Million
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $7.36 Million - $21.4 Million	606,003 Added 43.77%	1,990,607 $24.2 Million
Q4 2021 Feb 11, 2022	SELL	$30.49 - $48.49 $20.1 Million - $31.9 Million	-657,852 Reduced 32.21%	1,384,604 $47.2 Million
Q3 2021 Nov 12, 2021	BUY	$41.66 - $52.52 $48.8 Million - $61.5 Million	1,170,745 Added 134.3%	2,042,456 $98.5 Million
Q2 2021 Aug 13, 2021	BUY	$36.62 - $51.69 $31.8 Million - $44.9 Million	867,877 Added 22636.33%	871,711 $39.4 Million
Q1 2021 May 14, 2021	SELL	$41.56 - $59.88 $16,000 - $23,053	-385 Reduced 9.13%	3,834 $185,000
Q2 2020 Aug 11, 2020	BUY	$24.21 - $31.02 $25,323 - $32,446	1,046 Added 32.97%	4,219 $131,000
Q1 2020 May 15, 2020	BUY	$20.5 - $34.53 $65,046 - $109,563	3,173 New	3,173 $88,000
Q1 2019 May 15, 2019	SELL	$12.14 - $20.46 $10,476 - $17,656	-863 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$11.24 - $18.5 $9,700 - $15,965	863 New	863 $11,000

Others Institutions Holding NEO

# of Institutions

288

Shares Held

127M

Call Options Held

942K

Put Options Held

172K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $916M
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Neogenomics Inc Transaction History